+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive analysis of NuMA variation in breast cancer

Comprehensive analysis of NuMA variation in breast cancer

Bmc Cancer 8: 71

A recent genome wide case-control association study identified NuMA region on 11q13 as a candidate locus for breast cancer susceptibility. Specifically, the variant Ala794Gly was suggested to be associated with increased risk of breast cancer. In order to evaluate the NuMa gene for breast cancer susceptibility, we have here screened the entire coding region and exon-intron boundaries of NuMa in 92 familial breast cancer patients and constructed haplotypes of the identified variants. Five missense variants were further screened in 341 breast cancer cases with a positive family history and 368 controls. We examined the frequency of Ala794Gly in an extensive series of familial (n = 910) and unselected (n = 884) breast cancer cases and controls (n = 906), with a high power to detect the suggested breast cancer risk. We also tested if the variant is associated with histopathologic features of breast tumors. Screening of NuMA resulted in identification of 11 exonic variants and 12 variants in introns or untranslated regions. Five missense variants that were further screened in breast cancer cases with a positive family history and controls, were each carried on a unique haplotype. None of the variants, or the haplotypes represented by them, was associated with breast cancer risk although due to low power in this analysis, very low risk alleles may go unrecognized. The NuMA Ala794Gly showed no difference in frequency in the unselected breast cancer case series or familial case series compared to control cases. Furthermore, Ala794Gly did not show any significant association with histopathologic characteristics of the tumors, though Ala794Gly was slightly more frequent among unselected cases with lymph node involvement. Our results do not support the role of NuMA variants as breast cancer susceptibility alleles.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052269707

Download citation: RISBibTeXText

PMID: 18331640

DOI: 10.1186/1471-2407-8-71

Related references

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Human Molecular Genetics 19(19): 3873-3884, 2010

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Research 8(5): R54, 2006

Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). Journal of Clinical Endocrinology and Metabolism 96(2): E360-E367, 2011

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. Bmc Medical Genetics 8: 72, 2007

A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. International Journal of Cancer 142(6): 1182-1188, 2018

Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization. Journal of Cellular Biochemistry 114(4): 823-830, 2013

Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. Cancer Research 66(19): 9781-9785, 2006

The addition of taxanes to adjuvant chemotherapy for lymph node positive (N+) early breast cancer (BC): Institutional practice variation in the National Comprehensive Cancer Network (NCCN). Journal of Clinical Oncology 23(16_Suppl): 654-654, 2016

Retrospective analysis of breast cancer patients in a comprehensive diagnostic breast clinic. Breast Cancer Research & Treatment 10(1): 115, 1987

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches. Breast Cancer Research and Treatment 102(2): 237-247, 2007

Interdisciplinary Comprehensive Breast Tumor Boards: Their Role in the Comprehensive Management of Contemporary Breast Cancer. Seminars in Breast Disease 11(1): 4-8, 2008

Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk. Breast Cancer Research and Treatment 125(1): 207-214, 2011

Immunodetection of NuMA and MPM2-reactive antigens show distinctively different localization in the nucleus of both MCF-7 breast cancer and LNCaP prostate cancer cells. Molecular Biology of the Cell 10(Suppl. ): 197a, 1999

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. Human Genetics 135(1): 137-154, 2016

Evaluating Breast Cancer Care Coordination at a Rural National Cancer Institute Comprehensive Cancer Center Using Network Analysis and Geospatial Methods. Cancer Epidemiology Biomarkers and Prevention 28(3): 455-461, 2019